Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Size: px
Start display at page:

Download "Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015"

Transcription

1 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: v2016 Page 1

2 GLOSSARY Cumulative Prevalence It is also known as Prevalence for Life. Cases meet case definition criteria to qualify in a given year, and are then carried forward to show as a case every year thereafter. This measure is helpful for determining prevalence related to life long chronic disease, but less useful for conditions that may be episodic (e.g., mood disorders, substance use problem, etc.). Episodic Prevalence Cases meet case definition criteria to qualify in a given year, and are then carried forward in all subsequent years with at least one condition related code including ICD diagnostic codes, procedure codes or drugs in any specific year. Annual Prevalence Cases meet case definition criteria to qualify in each given year. Can be used as a quality measure to understand how it compares to cumulative prevalence or how it behaves over time. Annual Service Utilization Prevalence Cases meet case definition criteria in a given year by virtue of one hospital diagnosis (MRDX) or one physician claim with diagnosis (first position only). Cases are not carried forward from year to year. This utilization prevalence measure is useful for describing the number of people or proportion of the population using services directly related to the disease. Annual Prevalence with 365 Days follow up Cases meet case definition criteria to qualify in each given year with complete 365 days follow up time. Can be used as a quality measure to understand how it compares to cumulative prevalence or how it behaves over time. Page 2

3 CASE DEFINITION ASTHMA Case Definition Type: Cumulative Prevalence Episodic Prevalence Annual Prevalence Annual Service Utilization Prevalence Annual Prevalence with 365 Days Follow up Case Definition: The case definition for Asthma requires one hospitalization or two physician visits in one year, or 1 physician visit with an Asthma diagnostic code and 2 Asthma prescriptions in 1 year. The case definition applies to persons aged 1 and older. Signed off BC Case Definition: Yes V2016 No Algorithm: 1H or 2P in 1Y or 1P+2Rx in 1Y with ICD and/or drug code(s) specified below. Notes: None Age Restriction: Age 1 + Data Source(s): Data Source ICD Code/Procedure Code/Rx ICD Code/Procedure Code Position Hospital ICD 10 J45 First Position Only All Positions Others N/A Hospital ICD First Position Only All Positions Others N/A Diagnosis Type M Most Responsible Diagnosis 1 Pre Admit Comorbidity 2 Post Admit Comorbidity 3 Secondary Diagnosis 4 Morphology Code 5 Admitting Diagnosis 6 Proxy Most Responsible Diagnosis 9 External Cause of Injury Code 0 Newborn W,X,Y Service Transfer Diagnosis M Most Responsible Diagnosis 1 Pre Admit Comorbidity 2 Post Admit Comorbidity 3 Secondary Diagnosis 4 Morphology Code 5 Admitting Diagnosis 6 Proxy Most Responsible Diagnosis 9 External Cause of Injury Code 0 Newborn W,X,Y Service Transfer Diagnosis Hospital Care Level Acute Care Rehabilitation Day Surgery Acute Care Rehabilitation Day Surgery Page 3

4 Physician Claims ICD First Position Only N/A N/A All Positions Others N/A PharmaNet Drug History See drug list N/A N/A N/A Diagnostic Code: ICD 9/10 Description J45 Asthma 493 Asthma Procedure Code: N/A Drug List: DIN DRUGNAME DIN DRUGNAME ACCEL MONTELUKAST SODIUM TABLETS NU SALBUTAMOL 2MG/ML SOLN ACCOLATE TAB 20 MG NU SALBUTAMOL PLASTIC AMPULES 2 MG/ML ACET AM ELIX (D/C) NU SALBUTAMOL PLASTIC AMPULES 1 MG/ML ACET AM ELIX (D/C) NU THEOPHYLLINE SR 100MG TAB ACET AM ELIXIR (D/C) NU THEOPHYLLINE SR 200MG TAB ACET AM EXPECT (D/C) NU THEOPHYLLINE SR 300MG TAB ACET AM EXPECTORANT OMNARIS HFA ACET AM LIQ (D/C) ONBREZ BREEZHALER ACET AM TAB 325MG ORCIPREN ACH MONTELUKAST ORCIPRENALINE ACH MONTELUKAST ORCIPRENALINE 10MG/5ML SYR ADVAIR 100 DISKUS OXEZE TURBUHALER ADVAIR OXEZE TURBUHALER ADVAIR OXTRIPHYLLINE TAB 200MG ADVAIR 250 DISKUS OXTRIPHYLLINE TAB 300MG ADVAIR 50 INHALER PALARON ADVAIR 500 DISKUS PENDO MONTELUKAST AIROMIR PENDO MONTELUKAST ALOCRIL PENDO MONTELUKAST FC ALTI BECLOMETH 250MCG INH PENTA IPRATROPIUM BROMIDE ALTI BECLOMETHASONE DIPROPIONATE INHALER 50MCG/MD PHL IPRATROPIUM Page 4

5 ALTI IPRATROPIUM 20MCG INH PHL IPRATROPIUM 20ML ALTI SALBUTAMOL 0.4MG/ML LQ PHL IPRATROPIUM 1ML POLYNEB ALTI SALBUTAMOL 1.25 MG/2.5 ML PHL IPRATROPIUM 2ML POLYNEB ALTI SALBUTAMOL 5 MG/2.5 ML PHL IPRATROPIUM 250 MCG/2 ML ALUPENT AER PHL IPRATROPIUM 250 MCG/ML 3859 ALUPENT LIQ 50MG/ML PHL IPRATROPIUM 250 MCG/ML SOL ALUPENT SYR 10MG/5.0ML PHL IPRATROPIUM 250 MCG/ML SOL 3891 ALUPENT TAB 20MG PHL SALBUTAMOL ORAL LIQUID ALVESCO PHL SALBUTAMOL RESPIRATOR SOLUTION ALVESCO PHL SALBUTAMOL RESPIRATOR SOLUTION ALVESCO AEM 50MCG/ACT INH PHL SALBUTAMOL RESPIRATOR SOLUTION AMESEC PULVULE PHL SALBUTAMOL RESPIRATOR SOLUTION AMINOPHYL PHYLLOCONTIN AMINOPHYLLINE INJ 0.25GM PHYLLOCONTIN TABLETS 225MG AMINOPHYLLINE INJ 0.5GM PHYLLOCONTIN AMINOPHYLLINE INJ 25MG/ML PHYLLOCONTIN 350 TABLETS AMINOPHYLLINE INJ 25MG/ML PMS OXTRIPHYLLINE SYR PEDIATRIC 10MG/ML AMINOPHYLLINE INJ 25MG/ML PMS IPRATROPIUM AMINOPHYLLINE INJ 25MG/ML PMS IPRATROPIUM AMINOPHYLLINE INJ 50MG/ML PMS IPRATROPIUM (2ML UNIT DOSE) AMINOPHYLLINE INJ 50MG/ML PMS IPRATROPIUM (1ML UNIT DOSE) AMINOPHYLLINE INJ 50MG/ML PMS MONTELUKAST AMINOPHYLLINE INJECTION 25MG/ML PMS MONTELUKAST AMINOPHYLLINE INJECTION 50MG/ML PMS MONTELUKAST FC AMINOPHYLLINE SUP 7 1/2GR (D/C) PMS OXTRIPHYLLINE ELIXIR AMINOPHYLLINE TAB 0.1GM PMS SALBUTAMOL AMINOPHYLLINE TAB 0.2GM PMS SALBUTAMOL AMINOPHYLLINE TAB 100MG PMS SALBUTAMOL AMINOPHYLLINE TAB 100MG PMS SALBUTAMOL AMINOPHYLLINE TAB 200MG PMS SALBUTAMOL ORAL LIQUID APO OXTRIPHYLLINE TAB 100MG PMS SODIUM CROMOGLYCATE APO OXTRIPHYLLINE TAB 200MG PMS THEOPHYLLINE ELIXIR APO OXTRIPHYLLINE TAB 300MG POP A SELTER'S OVER INDULGENCE TABLETS APO CROMOLYN STERULES PRIMATENE TAB APO IPRAVENT SOLUTION INH 250MCG/ML PRIVA MONTELUKAST FC APO IPRAVENT STERULES PULMICORT INHALER 200MCG APO IPRAVENT STERULES PULMICORT INHALER 50MCG/AEM Page 5

6 APO MONTELUKAST PULMICORT NEBUAMP MG/ML APO MONTELUKAST PULMICORT NEBUAMP 0.25 MG/ML APO MONTELUKAST PULMICORT NEBUAMP 0.5 MG/ML APO SALVENT 5MG/ML PULMICORT SPACER 50MCG/AEM APO SALVENT AEM 100MCG PULMICORT SPACER INH 200MCG/AEM APO SALVENT CFC FREE PULMICORT TURBUHALER 100 MCG/DOSE APO SALVENT STERULES PULMICORT TURBUHALER 200 MCG/DOSE APO SALVENT STERULES PULMICORT TURBUHALER 400 MCG/DOSE APO SALVENT STERULES PULMOPHYLLINE ELX APO SALVENT TABLETS 2MG QUIBRON T SR TAB 300MG APO SALVENT TABLETS 4MG QUIBRON T SYR APO SALVENT IPRAVENT STERULES QVAR APO THEO ER QVAR APO THEO ER RAN MONTELUKAST APO THEO LA SRT 100MG RAN MONTELUKAST APO THEO LA SRT 200MG RAN MONTELUKAST APO THEO LA SRT 300MG RATIO IPRA SAL UDV ARNUITY ELLIPTA RATIO IPRATROPIUM INHALATION SOLUTION ARNUITY ELLIPTA RATIO IPRATROPIUM UDV ASBRON ELIXIR RATIO IPRATROPIUM UDV ASBRON ELIXIR/ (D/C) RATIO MONTELUKAST 10 MG TAB ASBRON TAB RATIO MONTELUKAST 4MG TAB CHEW ASMANEX TWISTHALER RATIO MONTELUKAST 5MG TAB CHEW ASMANEX TWISTHALER RATIO ORCIPRENALINE SYRUP 2MG/ML ASMANEX TWISTHALER RATIO SALBUTAMOL ASMAVENT NEBULES P.F RATIO SALBUTAMOL ASMAVENT RESPIRATOR SOLUTION INH 5MG/ML RATIO SALBUTAMOL ATROVENT RATIO SALBUTAMOL ATROVENT AEM 28.6MG/100GM RATIO SALBUTAMOL ATROVENT HFA RATIO SALBUTAMOL HFA ATROVENT UDV 125MCG/ML RESPBID SR TABS 250MG (D/C) ATROVENT UDV SOL INH 250MCG/ML RESPBID SR TABS 500MG (D/C) AURO MONTELUKAST RIVA MONTELUKAST 4 MG TAB CHEW AURO MONTELUKAST CHEWABLE TABLET RIVA MONTELUKAST 5 MG TAB CHEW AURO MONTELUKAST CHEWABLE TABLET RIVA MONTELUKAST FC AVA MONTELUKAST 10 MG TABLET ROUPHYLLINE SYR 10MG/ML AVA MONTELUKAST 4 MG TAB CHEW ROUPHYLLINE TAB 100MG Page 6

7 AVA MONTELUKAST 5 MG TAB CHEW ROUPHYLLINE TAB 200MG BCI SALBUTAMOL INHALATION SOLUTION RYNACROM ENCAPSULATED PWR BCI SALBUTAMOL INHALATION SOLUTION SABULIN INHALER 100MCG/METERED DOSE AEROSOL BECLODISK PWR INH 100MCG/BLISTER SALBU 5MG/ML INH SOLN BECLODISK PWR INH 200MCG/BLISTER SALBU 2 TAB 2MG BECLODISK PWR 100MCG/BLISTER SALBU 4 TAB 4MG BECLODISK PWR 200MCG/BLISTER SALBUTAMOL 1MG/ML NEBUAMP BECLOFORTE 250MCG/AEM SALBUTAMOL 1MG/ML SOLUTION BECLOFORTE INHALER SALBUTAMOL 2MG/ML NEBUAMP BECLOFORTE INHALER AEM INH 250MCG/AEM SALBUTAMOL 2MG/ML NEBUAMP BECLOMETHASONE DIPROPIONATE ORL INHALER SALBUTAMOL 2MG/ML STERULE BECLOVENT AEM 50MCG/AEM SALBUTAMOL HFA BECLOVENT AEM 50MCG/AEM SALBUTAMOL INHALATION SOLUTION BECLOVENT INHALER SALBUTAMOL INHALATION SOLUTION BECLOVENT ROTACAPS INH 100MCG/CAPSULE SALBUTAMOL INHALATION SOLUTION P.F. 1MG/ML BECLOVENT ROTACAPS INH 200MCG/CAP SALBUTAMOL NEBUAMP 0.05% BECLOVENT ROTACAPS 100MCG SALBUTAMOL NEBUAMP 0.1% BECLOVENT ROTACAPS 100MCG SALBUTAMOL NEBUAMP 0.2% BECLOVENT ROTACAPS 200MCG SALBUTAMOL RESP 5MG/ML SOL BECLOVENT ROTACAPS 200MCG SALBUTAMOL TAB 2MG BEROTEC 1MG/ML SALBUTAMOL TAB 4MG BEROTEC AEM 100MCG/DOSE SALMOL 2MG/ML INH SOLUTION BEROTEC FORTE METERED AER SANDOZ MONTELUKAST BEROTEC INHALER (D/C) SANDOZ MONTELUKAST BEROTEC TAB 2.5MG SANDOZ MONTELUKAST GRANULES BEROTEC UDV INHALATION SOLUTION 0.25MG/ML SANDOZ MONTELUKAST TABLET BEROTEC UDV INHALATION SOLUTON 0.625MG/ML SANDOZ SALBUTAMOL BIO MONTELUKAST SEREVENT (25MCG/ACTUATION) BREO ELLIPTA SEREVENT AEM 25MCG/AEM BREO ELLIPTA SEREVENT DISKHALER DISK (50MCG/DOSE) BRICANYL INHALER 0.25MG/AEM SEREVENT DISKUS (50MCG/DOSE) BRICANYL SPACER 0.25MG/UNIT/INHALER SEREVENT PWR 50MCG/BLISTER PACK BRICANYL TAB 2.5 MG SINGULAIR BRICANYL TAB 5 MG SINGULAIR BRICANYL TURBUHALER SINGULAIR CHOLEDYL ELIXIR 100MG/5ML SINGULAIR CHOLEDYL ELX 100MG/5ML (D/C) SLO BID 100 Page 7

8 CHOLEDYL EXPECT ELX (D/C) SLO BID CHOLEDYL EXPECT TAB (D/C) SLO BID CHOLEDYL EXPECTORANT ELIXIR SLO BID CHOLEDYL EXPECTORANT TAB SLO BID TIMED RELEASE CAPSULES 100MG CHOLEDYL PED SYR 10MG/ML (D/C) SLO BID TIMED RELEASE CAPSULES 200MG CHOLEDYL PEDIATRIC SYR 50MG/5ML SLO BID TIMED RELEASE CAPSULES 300MG CHOLEDYL SA TABLETS 400MG SLO BID TIMED RELEASE CAPSULES 50MG CHOLEDYL SA TABLETS 600MG SOMOPHYLLIN 12 SRC 100MG CHOLEDYL TAB 100MG SOMOPHYLLIN 12 SRC 200MG CHOLEDYL TAB 100MG (D/C) SOMOPHYLLIN 12 SRC 250MG CHOLEDYL TAB 200MG SOMOPHYLLIN 12 SRC 300MG CHOLEDYL TAB 200MG (D/C) SOMOPHYLLIN 12 SRC 50MG CHOLEDYL TAB 300MG SOMOPHYLLIN 12 SRC 350MG CHOLEDYL TAB 300MG (D/C) SOMOPHYLLIN 12 SRC 75MG CO SALBUTAMOL 2.5 MG/2.5 ML SOMOPHYLLIN T 100MG CO SALBUTAMOL 2MG/ML SOLN SOMOPHYLLIN T 200MG CO SALBUT IPRAT SOLUTION SOMOPHYLLIN T 250MG COMBIVENT INHALATION AEROSOL SYMBICORT 100 TURBUHALER COMBIVENT RESPIMAT SYMBICORT 200 TURBUHALER COMBIVENT UDV TANTA ORCIPRENALINE SYRUP SYR 2MG/ML COROPHYLLIN SUP 250MG TEVA COMBO STERINEBS COROPHYLLIN SUP 500MG TEVA IPRATROPIUM STERINEBS COROPHYLLIN SUP 500MG (D/C) TEVA MONTELUKAST DIUERB TAB TEVA MONTELUKAST DOM MONTELUKAST TEVA MONTELUKAST DOM MONTELUKAST TEVA SALBUTAMOL STERINEBS P.F DOM MONTELUKAST FC TEVA SALBUTAMOL STERINEBS P.F DOM SALBUTAMOL 1.25 MG/2.5 ML TEVA THEOPHYLLINE SR DOM SALBUTAMOL 2MG/ML SOLN TEVA THEOPHYLLINE SR DOM SALBUTAMOL 5MG/ML SOLN TEVA THEOPHYLLINE SR DOM SALBUTAMOL RESPIRATOR SOLUTION 1MG/ML THEO DUR SRT 100MG DUAKLIR GENUAIR THEO ER DUOVENT UDV THEO ER ELIXIR DE THEOPHYLLINE THEO ORGANIDIN ELIXOPHYLLIN 200MG CAP (D/C) THEOCHRON SRT 100MG ELIXOPHYLLIN CAP 100MG (D/C) THEOCHRON SRT 200MG ELIXOPHYLLIN CAP 200MG THEOCHRON SRT 300MG Page 8

9 ELIXOPHYLLIN CAP 200MG (D/C) THEO DUR 100 MG ELIXOPHYLLIN ELX (D/C) THEO DUR 200 MG ELIXOPHYLLIN ELX 80MG/15ML THEO DUR 300 MG ELIXOPHYLLIN K THEO DUR 450 MG ELIXOPHYLLIN K1 ELX (D/C) THEO DUR SPRINKLE SRC 125MG ELIXOPHYLLIN K1 LIQ (D/C) THEO DUR SPRINKLE SRC 200MG ELIXOPHYLLIN LIQ (D/C) THEO DUR SPRINKLE SRC 50MG ENTAIR CAP (D/C) THEO DUR SPRINKLE SRC 75MG FLOVENT 0.5MG/2ML NEBULE THEOLAIR FLOVENT 100 MCG DISKUS THEOLAIR 125MG TAB FLOVENT 250 MCG DISKUS THEOLAIR 250 TAB FLOVENT 50 MCG DISKUS THEOLAIR LIQ FLOVENT 500 MCG DISKUS THEOLAIR SR 200MG TAB FLOVENT DISKUS THEOLAIR SR 250MG FLOVENT DISKUS THEOLAIR SR 300MG FLOVENT DISKUS THEOLAIR SR 500MG FLOVENT DISKUS THEOLAIR SR TAB 200MG FLOVENT DISKUS 100MCG/BLIST THEOLAIR SR TAB 250MG FLOVENT DISKUS 250MCG/BLIST THEOLAIR SR TAB 300MG FLOVENT DISKUS 500MCG/BLIST THEOLAIR SR TAB 500MG FLOVENT DISKUS 50MCG/BLSTR THEOLAIR TAB 125MG FLOVENT HFA THEOLAIR TAB 250MG FLOVENT HFA THEOPHYLLINE 0.8MG AND 5% DEXTROSE INJ FLOVENT HFA THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJ FLOVENT INHALERS AEM INH ORL 125MCG/AEM THEOPHYLLINE 1.6MG AND 5% DEXTROSE INJ FLOVENT INHALERS AEM INH ORL 250MCG/AEM THEOPHYLLINE 4MG AND 5% DEXTROSE INJ FLOVENT INHALERS AEM INH ORL 25MCG/AEM THEOPHYLLINE 80MG/15ML FLOVENT INHALERS AEM INH ORL 50MCG/AEM THEOPHYLLINE AND 5% DEXTROSE INJ 0.8MG/ML FLOVENT INHALERS AEM INH ORL 25MCG/ACTUATION THEOPHYLLINE AND 5% DEXTROSE INJ 1.6MG/ML FLOVENT INHALERS AEM INH ORL 50MCG/ACTUATION THEOPHYLLINE AND 5% DEXTROSE INJ 4MG/ML FLOVENT INHALERS AEM INH ORL125MCG/ACTUATION THEOPHYLLINE ELIXIR FLOVENT INHALERS AEM INH ORL250MCG/ACTUATION THEOPHYLLINE ELIXIR FORADIL DRY POWDER CAPSULES FOR INHALATION THEOPHYLLINE ELX FRANOL TAB (D/C) THEOPHYLLINE KI ELX FTP SALBUTAMOL 1MG/ML NEB THEOPHYLLINE ROUGIER ELIXIR GEN COMBO STERINEBS SOL INH THEO SR 200 SRT 200MG GEN CROMOGLYCATE STERINEBS LIQ INH 1% THEO SR 300 SRT 300MG Page 9

10 INTAL INHALER THEO SR SRT 200MG INTAL NEBULIZER 1% THEO SR SRT 300MG INTAL SPINCAPS 20MG TILADE INTAL SYNCRONER TILADE INHALER 2MG/AEM IPG MONTELUKAST ULTIBRO BREEZHALER IPG MONTELUKAST UNI MONTELUKAST IPG MONTELUKAST UNI MONTELUKAST IPRAMOL UNI MONTELUKAST IPRATROPIUM 250 MCG/2 ML SOLN UNIPHYL IPRATROPIUM 250 MCG/ML SOLN UNIPHYL IPRATROPIUM 250 MCG/ML SOLN UNIPHYL TAB 400MG IPRATROVENT 250 MCG/ML SOLN UNIPHYL TAB 600MG JAA AMINOPHYLLINE TAB 100MG VAN MONTELUKAST JAMP MONTELUKAST VAN MONTELUKAST JAMP MONTELUKAST VAN MONTELUKAST JAMP MONTELUKAST VENTODISK 200MCG MAR MONTELUKAST VENTODISK 400MCG MAR MONTELUKAST VENTODISK PWR 200MCG/BLISTER MAR MONTELUKAST VENTODISK PWR 400MCG/BLISTER MED IPRATROP 250 MCG/ML SOLN VENTOLIN DISKUS MED IPRATROPIUM 250 MCG/ML SOL VENTOLIN HFA MED SALBUTAMOL INHALATION SOLUTION 1MG/ML VENTOLIN I V BOLUS INJ.05MG/ML MED SALBUTAMOL 2MG/ML SOLN VENTOLIN I.M. INJECTION 0.5MG SALBUTAMOL IN 1 ML (500MCG/ML) MINT MONTELUKAST VENTOLIN I.V. BOLUS INJECTION 0.25MG SALBUTAMOL IN 5ML (50MC) MINT MONTELUKAST VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (100MC) MINT MONTELUKAST VENTOLIN IM INJ 0.5MG/ML MIREZE VENTOLIN IM INJ 0.5MG/ML MONTELUKAST VENTOLIN INHALER MONTELUKAST VENTOLIN INHALER MONTELUKAST VENTOLIN INHALER (D/C) MONTELUKAST VENTOLIN INHALER 100MCG/AEM MONTELUKAST VENTOLIN INJECTION LIQ IV 5MG/5ML MONTELUKAST VENTOLIN IV BOLUS INJ 0.05MG/ML MONTELUKAST VENTOLIN IV INFUSION 0.5MG/ML MONTELUKAST VENTOLIN IV INFUSION 0.5MG/ML MONTELUKAST VENTOLIN NEBULES 1MG/ML MONTELUKAST VENTOLIN NEBULES P.F. 2.5MG/2.5ML Page 10

11 MONTELUKAST 10 MG TABLET VENTOLIN NEBULES P.F. 5MG/2.5ML MONTELUKAST 4 MG CHEWABLE TAB VENTOLIN NEBULES P.F. 1.25MG/2.5ML MONTELUKAST 4 MG GRANULES VENTOLIN NEBULES P.F. LIQ INH 1.25MG/2.5ML MONTELUKAST 5 MG CHEWABLE TAB VENTOLIN NEBULES P.F. SOL 2.5MG/2.5ML MONTELUKAST SODIUM TABLETS VENTOLIN NEBULES PF SOL 5MG/2.5ML MYLAN IPRATROPIUM SOLUTION VENTOLIN ORAL LIQUID MYLAN MONTELUKAST VENTOLIN ORAL LIQUID 0.4MG/ML MYLAN MONTELUKAST VENTOLIN ORAL LIQUID 0.4MG/ML MYLAN MONTELUKAST VENTOLIN RESPIRATOR SOLUTION MYLAN SALBUTAMOL RESPIRATOR SOLUTION VENTOLIN RESPIRATOR SOLUTION NALCROM VENTOLIN RESPIRATOR SOLUTION 5MG/ML NOVO CROMOLYN NEBULIZER SOLUTION 1% VENTOLIN ROTACAPS NOVO IPRAMIDE LIQ 0.25MG/ML VENTOLIN ROTACAPS NOVO SALBUTAMOL HFA VENTOLIN ROTACAPS 200MCG NOVO SALMOL INHALER 100MCG/AEM VENTOLIN ROTACAPS 200MCG NOVO SALMOL TAB 2MG VENTOLIN ROTACAPS 200MCG NOVO SALMOL TAB 4MG VENTOLIN ROTACAPS 400MCG NOVO TRIPHYL TAB 100MG VENTOLIN ROTACAPS 400MCG NOVO TRIPHYL TAB 200MG VENTOLIN TAB 2MG NOVO TRIPHYL TAB 300MG VENTOLIN TAB 2MG NTP MONTELUKAST VENTOLIN TAB 4MG NTP MONTELUKAST VENTOLIN TAB 4MG NTP MONTELUKAST VOLMAX TABLET SRT 4MG NU CROMOLYN PLASTIC AMPULES VOLMAX TABLET SRT 8MG NU IPRATROPIUM 250 MCG/ML SOL XOLAIR NU IPRATROPIUM PLASTIC AMPULES 250 MCG/ML ZENHALE NU ORCIPRENALINE ZENHALE NU SALBUTAMOL TAB 2MG ZENHALE NU SALBUTAMOL TAB 4MG Page 11

12:00 Autonomic Drugs 12:00. Autonomic Drugs

12:00 Autonomic Drugs 12:00. Autonomic Drugs Autonomic Drugs Autonomic Drugs 12:04 PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS PILOCARPINE HCL 5 MG ORAL TABLET 00002216345 SALAGEN 1.4298 PYRIDOSTIGMINE BROMIDE 60 MG ORAL TABLET 00000869961 MESTINON

More information

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:

More information

Inhalers containing CFCs. CFC-free inhalers

Inhalers containing CFCs. CFC-free inhalers Propellants used in medical metered dose inhalers and aerosol-based breath activated devices in New Zealand August to October 2002 (most recent period for which data is available) (February 2003) Inhalers

More information

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution

More information

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program

More information

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:

More information

Methacholine Challenge Test

Methacholine Challenge Test PATIENT & CAREGIVER EDUCATION Methacholine Challenge Test This information will help you prepare for your methacholine challeng e test at Memorial Sloan Kettering (MSK). A methacholine (meth-a-kole-leen)

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

Inhalation devices, proper technique and cleaning

Inhalation devices, proper technique and cleaning Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly

More information

Key features and changes to these four components of asthma care include:

Key features and changes to these four components of asthma care include: Guidelines for the Diagnosis and Management of Asthma in Adults Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions regarding

More information

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy Update: Focus on Intensifying LABA, LAMA and ICS Therapy B.C. Provincial Academic Detailing Service February 2017 Background In Canada, approximately 20 inhaled medications are approved to treat Chronic

More information

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines

More information

Foundations of Pharmacology

Foundations of Pharmacology Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids

More information

APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe

APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe Instructions: Print on 8.5 x14 (216 x 279 mm) paper (Legal size) Medication in Green Zone Change

More information

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Objectives Categorize the new asthma and COPD inhalers in to existing or newly created categories Discuss the

More information

End Stage COPD Guidance Document

End Stage COPD Guidance Document End Stage COPD Guidance Document Suggested Guidelines for the Determination of Hospice Eligibility A patient with severe chronic pulmonary disease that meets the following criteria may be eligible for

More information

Common Inhaled Asthma Medications Dose Comparison and Tips for Use

Common Inhaled Asthma Medications Dose Comparison and Tips for Use Detail-Document #210303 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER March 2005 ~ Volume 21 ~ Number 210303 Common Inhaled Asthma Medications

More information

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2014 Step Therapy Criteria (List of Step Therapy Criteria) Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT

More information

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 12 Years and Older

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 12 Years and Older Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 12 Years and Older The Canadian Thacic Society recommends a tempary, greater

More information

Diagnosis and Management of Asthma

Diagnosis and Management of Asthma Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:

More information

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints

More information

YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 B BECLOMETHASONE BECEZE 50MCG INHALER

YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 B BECLOMETHASONE BECEZE 50MCG INHALER Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular

More information

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section.

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section. Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACLIDINIUM BROMIDE bronchodilators ADRENALINE/EPINEPHRINE

More information

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida Prasad Peri, Ph.D., Branch Chief, ONDQA, FDA March 19, 2014 1 Topics for discussion Introduction

More information

SUPPLEMENTARY MATERIAL. Supplementary methods. Optimum Patient Care questionnaires

SUPPLEMENTARY MATERIAL. Supplementary methods. Optimum Patient Care questionnaires 1 SUPPLEMENTARY MATERIAL Supplementary methods Optimum Patient Care questionnaires Over 600 primary care practices in the United Kingdom contribute data to the Optimum Patient Care Research Database (OPCRD).

More information

Please also see section on Drugs used in substance dependence for patients with established chemical dependence

Please also see section on Drugs used in substance dependence for patients with established chemical dependence Respiratory System Algorithm for the selection of the most appropriate inhaler device for patients with chronic stable asthma Information on Inhaler devices Devices β 2 agonist bronchodilators Antimuscarinic

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung

More information

Respiratory Health. Asthma and COPD

Respiratory Health. Asthma and COPD Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory

More information

Inhaled Corticosteroid Dose Comparison in Asthma

Inhaled Corticosteroid Dose Comparison in Asthma This Clinical Resource gives subscribers additional insight related to the Recommendations published in April 2017 ~ Resource #330402 Inhaled Corticosteroid Dose Comparison in Asthma The chart below provides

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #973 April 30, 2018 NB Drug Plans Formulary Update Generic drug product updates included in this bulletin: Generic drug product additions - New generic products will be reimbursed up to the category

More information

reslizumab (Cinqair )

reslizumab (Cinqair ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

benralizumab (Fasenra )

benralizumab (Fasenra ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency

More information

MDI Bonanza. Dwayne Griffin, DO

MDI Bonanza. Dwayne Griffin, DO MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing

More information

YES = formulary NO = non-formulary NO BENEFIT = excluded

YES = formulary NO = non-formulary NO BENEFIT = excluded Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular

More information

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications

More information

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Medications Affecting The Respiratory System

Medications Affecting The Respiratory System Medications Affecting The Respiratory System Overview Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects

More information

Report generated from BNF with QVH Formulary provided by FormularyComplete ( Accessed Formulary Status.

Report generated from BNF with QVH Formulary provided by FormularyComplete (  Accessed Formulary Status. Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015 Title Formulary Status Section TA Number TA Link Annotation A2A Spacer Able Spacer Accolate

More information

Alberta Childhood Asthma Pathway for Primary Care

Alberta Childhood Asthma Pathway for Primary Care Asthma Diagnosis Box 1 Diagnosis: Based on symptom pattern, careful and thorough history of symptoms (wheeze, cough, night waking and activity limitations), and assessment of family history of asthma and

More information

Cinqair (reslizumab injection for intravenous use)

Cinqair (reslizumab injection for intravenous use) Cinqair (reslizumab injection for intravenous use) Policy Number: 5.02.522 Last Review: 04/2018 Origination: 04/2016 Next Review: 04/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual

More information

Pequot Health Care Smart Quantity Program*

Pequot Health Care Smart Quantity Program* Pequot Health Care 1 Annie George Drive Mashantucket, CT 06338 Phone: 1-888-779-6638 Fax: 1-860-396-6494 Pequot Health Care Smart Quantity Program* Updated January 2018 *Quantity Program limits apply to

More information

Respiratory Medications and Devices Update 2/15

Respiratory Medications and Devices Update 2/15 Respiratory Medications and Devices Update 2/15 Dewey Hahlbohm, PA-C, AE-C Wendy Brown, Pharm.D., MPAS, PA-C, AE-C Objectives! Review mechanism of action for asthma pharmacologic agents! Describe key patient

More information

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older

Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older The Canadian Thoracic Society and other international asthma

More information

Correct Use of Inhaler Devices

Correct Use of Inhaler Devices PL Detail-Document #300206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Correct Use of

More information

GUIDELINES & PROTOCOLS

GUIDELINES & PROTOCOLS GUIDELINES & PROTOCOLS ADVISORY COMMITTEE Chronic Obstructive Pulmonary Disease (COPD) Effective Date: January 1, 2011 Scope This guideline provides strategies for the improved diagnosis and management

More information

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL* Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

More information

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual

More information

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption To help make the use of prescription drugs safer and more affordable, our plan is now using a Drug Quantity Management program. That is, for certain medications, you can receive an amount to last you a

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes December 2013 Effective January 03, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

Aerospan (flunisolide)

Aerospan (flunisolide) STRENGTH DOSAGE FORM ROUTE GPID 80mcg/actuation HFA aerosol inhaler w/ Inhaled 35718 8.9 g/canister adapter MANUFACTURER Meda Pharmaceuticals INDICATION Aerospan Inhalation Aerosol is indicated for the

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - February 2015 Effective February 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

RESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18

RESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18 impact500 www.ccgprescriber.org RESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18 TOTAL AVAILABLE NHS SAVINGS IN THIS EDITION 133 MILLION EDITION TWO Analysis was undertaken using May 2017 tariff and February

More information

Common Drug Review Pharmacoeconomic Review Report

Common Drug Review Pharmacoeconomic Review Report Common Drug Review Pharmacoeconomic Review Report January 2018 Drug umeclidinium bromide (Incruse Ellipta) Indication Listing request Dosage form(s) Manufacturer Indicated for long-term, once daily maintenance

More information

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device What Device am I Class Side Effects History Potpourri Monitoring Tools 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 WHAT KIND OF DEVICE AM I? I was one of the first dry power

More information

Nucala (mepolizumab injection for subcutaneous use)

Nucala (mepolizumab injection for subcutaneous use) Nucala (mepolizumab injection for subcutaneous use) Policy Number: 5.01.612 Last Review: 01/2018 Origination: 02/2016 Next Review: 02/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

CAMPER APPLICATION PACKET

CAMPER APPLICATION PACKET CAMPER APPLICATION PACKET Monday- Friday June 12-16, 2017 Rockport, Texas DEADLINE FOR SUBMITTING ALL FORMS: THE IMPORTANCE OF COMPLETING ALL CAMP FORMS Although it may seem like a lot of paperwork, the

More information

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules

More information

Better Living with Obstructive Pulmonary Disease A Patient Guide

Better Living with Obstructive Pulmonary Disease A Patient Guide Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health a Better Living with Chronic Obstructive Pulmonary Disease A Patient Guide is a joint project

More information

Asthma. Definition. Symptoms

Asthma. Definition. Symptoms Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some

More information

Reference Guide for Caring for Pediatric Patients with Asthma

Reference Guide for Caring for Pediatric Patients with Asthma Reference Guide for Caring for Pediatric Patients with Asthma Co-Chair: Nancy Cantey Banasiak, DNP, PPCNP-BC, APRN Co-Chair: Deborah Hickman, DNP, APRN-CNP, CPNP-PC, NNP-BC Asthma and Allergy SIG Members

More information

The Medical Letter. on Drugs and Therapeutics

The Medical Letter. on Drugs and Therapeutics The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop INHALERS for COPD Dr Christopher Worsnop Department of Respiratory Medicine Austin Hospital INTRODUCTION Most drugs for COPD are given via inhalers. This reduces the dose that needs to be given and delivers

More information

AT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care

AT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care 1 1 Should the child be placed into the Pathway? Asthma Clinical Score (PRAM) Inclusion Children 1 year and 18 years of age who present with wheezing and respiratory distress, and have been diagnosed by

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

COPD The New Epidemic. Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre

COPD The New Epidemic. Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre COPD The New Epidemic Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre Conflict Disclosure Information Speaker: Dr. Peter Lin Title of Talk: COPD The New Epidemic Financial

More information

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: This form should be completed during the participant s clinic visit. 1) Are you regularly

More information

Sample. Affix patient label within this box.

Sample. Affix patient label within this box. Instructions for completing orders Complete pages 1-3 for General Inpatient Orders. All pathway compatible orders (indicated by ) within the General Inpatient Orders will be followed automatically. Optional

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex

More information

Breath of Fresh Air. for the health of the nation, stated in Healthy People 2010,

Breath of Fresh Air. for the health of the nation, stated in Healthy People 2010, Volume 7, No. 4 Spring 2003 Asthma Trends in the United States In 1996, when asked During the past 12 months, have you had asthma?, 14.6 million Americans responded yes on behalf of themselves or their

More information

Learning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management

Learning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management Marliese Gibson PharmD HospiScript, a Catalyst Rx Company May 16, 2012 Chronic Obstructive Pulmonary Disease Learning Objectives Review normal lung function and COPD pathophysiology Discuss pharmacological

More information

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Commissioner for the Department for Medicaid Services Selections for Preferred Products Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for

More information

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Lindsay Thomas, Pharm.D. PGY2 Ambulatory Care Resident Department of Pharmacotherapy and Pharmacy

More information

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS:

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS: MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS: LOB: Respiratory Disorders Medi-Cal REVIEW HISTORY (MONTH/YEAR) 12/17,12/16, 5/15,

More information

Drug Effectiveness Review Project Summary Report

Drug Effectiveness Review Project Summary Report Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Inhaled Corticosteroids Drug Class Prior Authorization Protocol Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Select Inhaled Respiratory Agents

Select Inhaled Respiratory Agents Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C Director, Commercial Care

More information

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Inhaled Corticosteroids Drug Class Prior Authorization Protocol Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

Respiratory Inhalers. Identification Guide Version 3

Respiratory Inhalers. Identification Guide Version 3 Respiratory Inhalers Identification Guide Version 3 This booklet has been prepared by NHSGGC Medicines Information. Endorsed by NHSGGC Respiratory Managed Clinical Network, February 2017. Designed by Medical

More information

Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management

Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management Table of Contents Policy: Commercial Information Pertaining to All Policies Endnotes Policy: Medicare References

More information

Staying Healthy. with Asthma. Illustrations by paulsharp.com

Staying Healthy. with Asthma. Illustrations by paulsharp.com Staying Healthy with Asthma Illustrations by paulsharp.com Lungs & Asthma What is Asthma? Inflammation or swelling of airways that leads to: 1) Mucous production deep inside the airways. 2) Temporary difficulty

More information

Asthma. Introduc:on. Introduc:on. Anatomic Altera:ons of the Lungs. Introduc:on. RSPT 2310 Asthma RSPT 2310

Asthma. Introduc:on. Introduc:on. Anatomic Altera:ons of the Lungs. Introduc:on. RSPT 2310 Asthma RSPT 2310 DMC = Degranula:on of mast cell MA = Mucus accumula:on HALV = Hyperinfla:on of alveoli MP = Mucus plug SMC = Smooth muscle constric:on RSPT 2310 Introduc:on The first evidence based asthma guidelines were

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario

More information

Physician Orders ADULT: LEB Asthma Admit Plan. Anticipated LOS: 2 midnights or more Patient Status Initial Outpatient T;N Attending Physician:

Physician Orders ADULT: LEB Asthma Admit Plan. Anticipated LOS: 2 midnights or more Patient Status Initial Outpatient T;N Attending Physician: Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase, Phase: LEB Asthma Admit Phase, When to Initiate: LEB Asthma Admit Phase Non Categorized Add To Problem List Problem: Asthma

More information

3 RESPIRATORY SYSTEM

3 RESPIRATORY SYSTEM 3 RESPIRATORY SYSTEM 3.01 ANTIASTHMATICS 3.01a BETA 2 AGONIST ASTHMA, CHRONIC BRONCHITIS & EMPHYSEMA Salbutamol Inhaler 100ug/dose [Albuterol] (Ventolin) Salbutamol Sulphate Respirator Solution 0.5% (5mg/ml),

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY CLINICAL MEDICAL POLICY Policy Name: Xolair (omalizumab) Policy Number: MP-051-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Original Effective

More information

FASENRA (benralizumab)

FASENRA (benralizumab) FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate

More information

Adult Emergency Department Asthma Care Pathway (EDACP)

Adult Emergency Department Asthma Care Pathway (EDACP) Adult Emergency Department Asthma Care Pathway (EDACP) June, 2018 Contact Information Email: info@lungontario.ca Phone: 1-888-344-LUNG (5864) Fax: 416-922-9430 Adult Emergency Department Asthma Care Pathway

More information

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Goals of Therapy Asthma Prevent symptoms COPD Reduce COPD symptoms Decrease use of SABAs Maintain normal pulm function & prevent loss

More information